Analystreport

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its price target lowered by analysts at Raymond James from $84.00 to $83.00. They now have a "strong-buy" rating on the stock.

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report